FDA DEVICE FACTS
ACCU NEWS Drug Screening Test Card/Urine Cup
Coretests, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The ACCU NEW® Drug Screening Test Card/Urine Cup are immunochromatographic assays for the qualitative determination of the drugs/drug metabolites in human unne. The test cutoff concentrations and the compounds the tests are calibrated to are as follows:
Analyte Abbreviation Calibrator Cutoff (ng/ml) Amphetamine AMP d-Amphetamine 1000 Methamphetamine MET d-Methamphetamine 1000 Morphine MOP Morphine 300 Cocame coc Benzoylecgonine 300 Marijuana THC 11-Nor-9-THC-9-COOH 50
The ACCU NEWS® Dmg Screening Test Card /Urine Cup can consist of any combination of the drug analytes listed above.
For in vitro diagnostic use only. The tests are intended for both prescription and over-the-counter (OTC) use.
The device provides only a preliminary result. A more specific alternative chemical method must be used im order to obtain a confirmed result. Gas Chromatography/Mass Spectrometry (GC/MS) or Liquid Chromatography/Mass Spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgement should be exercised for any drugs of abuse test results, particularly when preliminary results are positive.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。